Last update 01 Nov 2024

Mertuzumab(Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd)

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms-
Target
BSG
Mechanism
BSG inhibitors(Basigin inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects)
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Non-Small Cell Lung Cancer
Inactive Indication-
Originator Organization
Jiangsu Pacific Meinok Biopharmaceutical Co., Ltd.Jiangsu Pacific Meinok Biopharmaceutical Co., Ltd.
Active Organization
The Fourth Military Medical University of the Chinese People's Liberation ArmyJiangsu Pacific Meinok Biopharmaceutical Co., Ltd.Jiangsu Pacific Meinok Biopharmaceutical Co., Ltd.
Inactive Organization
People's Liberation Army Air Force Military Medical UniversityPeople's Liberation Army Air Force Military Medical University
Drug Highest PhasePhase 1
First Approval Date-
RegulationSpecial Review Project (CN)
Login to view timeline

Related

1
Clinical Trials associated with Mertuzumab(Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd)
CTR20150433 / RecruitingPhase 1
考察美妥珠（HcHAb18）单抗注射液安全性、耐受性和药代动力学的单中心、开放、剂量递增的Ia期临床研究
[Translation] A single-center, open-label, dose-escalating Phase Ia clinical study to investigate the safety, tolerability, and pharmacokinetics of metoprolol (HcHAb18) monoclonal antibody injection
100 Clinical Results associated with Mertuzumab(Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd)
Login to view more data
100 Translational Medicine associated with Mertuzumab(Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd)
Login to view more data
100 Patents (Medical) associated with Mertuzumab(Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd)
Login to view more data
100 Deals associated with Mertuzumab(Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Small Cell Lung CancerPhase 1
CN
The Fourth Military Medical University of the Chinese People's Liberation Army
07 Jul 2015
Non-Small Cell Lung CancerPhase 1
CN
Jiangsu Pacific Meinok Biopharmaceutical Co., Ltd.Jiangsu Pacific Meinok Biopharmaceutical Co., Ltd.
07 Jul 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free